{
    "clinical_study": {
        "@rank": "63576", 
        "acronym": "DIGEST", 
        "arm_group": [
            {
                "arm_group_label": "TZP-102 three times a day", 
                "arm_group_type": "Experimental", 
                "description": "10 mg TZP-102 will be taken 30 minutes prior to each main meal for a total of three daily doses."
            }, 
            {
                "arm_group_label": "Placebo three times a day", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo will be taken 30 minutes prior to each main meal for a total of three daily doses."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the safety and effectiveness of 10 mg TZP-102 given\n      prior to meals three times a day compared to placebo (capsule that looks like active study\n      drug but contains no active drug), administered for 12 weeks, in diabetic subjects with\n      symptoms associated with gastroparesis."
        }, 
        "brief_title": "Diabetic Gastroparesis Efficacy/Safety Study of TZP-102", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Gastroparesis", 
        "condition_browse": {
            "mesh_term": "Gastroparesis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 to 80 years of age inclusive\n\n          -  Type 1 or type 2 diabetes mellitus\n\n          -  History of symptoms of gastroparesis for at least 3 months leading up to the\n             Screening Visit\n\n          -  Documented delayed gastric emptying\n\n          -  Upper gastrointestinal obstruction ruled out by endoscopy or barium scan\n\n          -  Concomitant medications must be stable for at least 2 weeks leading up to the\n             Screening visit and must be maintained during the study.\n\n          -  Females of child-bearing potential must have a negative serum pregnancy test and use\n             (and agree to continue to use throughout the study) an acceptable form of\n             contraception\n\n        Exclusion Criteria:\n\n          -  Gastrectomy, bariatric surgery, fundoplication or vagotomy/pyloroplasty\n\n          -  Has had or plans to have endoscopic pyloric injections of botulinum toxin within 6\n             months prior to the Screening Visit or during the study\n\n          -  NG, PEG or PEJ feeding tube or inpatient hospitalization for gastroparesis within 2\n             weeks prior to the Screening Visit\n\n          -  Required parenteral nutrition for treatment of gastroparesis within 2 months prior to\n             the Screening Visit\n\n          -  Active gastric pacemaker within 3 months prior to the Screening Visit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01664637", 
            "org_study_id": "TZP-102-CL-G004"
        }, 
        "intervention": [
            {
                "arm_group_label": "TZP-102 three times a day", 
                "description": "One oval-shaped, opaque-white, hard gelatin capsule containing active ingredient will be taken orally three times a day for 12 weeks", 
                "intervention_name": "10 mg TZP-102", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo three times a day", 
                "description": "One oval-shaped, opaque-white, hard gelatin capsule of placebo indistinguishable from active drug will be taken orally three times a day for 12 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "diabetic gastroparesis", 
            "delayed gastric emptying", 
            "gastroparesis", 
            "diabetes mellitus, Type 1", 
            "diabetes mellitus, Type 2"
        ], 
        "lastchanged_date": "December 18, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35801"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85710"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72117"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90822"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ventura", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93003"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hialeah", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33016"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Inverness", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34452"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32256"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33183"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33144"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Smyrna Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32168"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anderson", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46106"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monroe", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "71201"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65265"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salisbury", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28144"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73104"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "El Paso", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79905"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland", 
                        "zip": "15732"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland", 
                        "zip": "15950"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bydgoszcz", 
                        "country": "Poland", 
                        "zip": "85094"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kielce", 
                        "country": "Poland", 
                        "zip": "25035"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland", 
                        "zip": "31530"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "90251"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20607"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20090"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olsztyn", 
                        "country": "Poland", 
                        "zip": "10561"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rzeszow", 
                        "country": "Poland", 
                        "zip": "35073"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "02097"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zgierz", 
                        "country": "Poland", 
                        "zip": "95100"
                    }, 
                    "name": "Tranzyme Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Poland"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Efficacy and Safety of TZP-102 Given Orally Three Times a Day for the Treatment of Symptoms Associated With Diabetic Gastroparesis", 
        "overall_official": {
            "affiliation": "Tranzyme, Inc.", 
            "last_name": "Elsa Mondou, M.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in symptoms associated with diabetic gastroparesis", 
            "safety_issue": "No", 
            "time_frame": "12 Weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01664637"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in health-related quality of life", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }, 
            {
                "measure": "Adverse events (AEs), vital signs, ECGs, clinical laboratory parameters", 
                "safety_issue": "Yes", 
                "time_frame": "12 Weeks"
            }
        ], 
        "source": "Tranzyme, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tranzyme, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012", 
        "why_stopped": "Insufficient efficacy in planned interim futility analysis"
    }
}